NFE2L2 and cancer: However, NRF2 has controversial roles in cancer [55]; that is, NRF2 may be protective in the early stages of cancer but may be tumorigenic in the advanced stages (i.e., activated NRF2 may not only prevent ROS-induced oncogenic mutations, but also promote tumor cell survival by inhibiting apoptosis) [39].